Shannon L. Devers serves as Executive at IONIS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Shannon L. Devers has executed 11 insider transactions totaling $2.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 22, 2026 involved selling 3,977 shares valued at $323.5K.
Shannon L. Devers currently holds 22,541 shares of IONIS PHARMACEUTICALS INC (IONS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shannon L. Devers has been a net seller of IONS stock. They have purchased $0 and sold $2.4M worth of shares.
Shannon L. Devers's most recent insider trade was on Jan 22, 2026, when they sold 3,977 shares at $81.34 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Nov 25, 2025 | IONS | $902.1K | Option Exercise | 16,777 | $53.77 | Discretionary |
| Nov 25, 2025 | IONS | $1.4M | Sale | 16,777 | $80.91 | Discretionary |
| Oct 16, 2025 | IONS | $93.0K | Sale | 1,263 | $73.62 | Discretionary |
| Oct 15, 2025 | IONS | $291.1K | Option Exercise | 6,000 | $48.51 | Discretionary |
| Oct 15, 2025 | IONS | $437.6K | Sale | 6,000 | $72.94 | Discretionary |
| Oct 15, 2025 | IONS | $0 | Option Exercise | 2,820 | $N/A | Discretionary |
| Sep 3, 2025 | IONS | $84.0K | Option Exercise | 2,234 | $37.58 | Discretionary |
| Sep 3, 2025 | IONS | $30.3K | Option Exercise | 928 | $32.60 | Discretionary |
| Sep 3, 2025 | IONS | $192.9K | Sale | 3,162 | $61.02 | Discretionary |